Synthetic biology startups are engineering microbes to produce industrial chemicals, fragrances, and materials that once came exclusively from petroleum, betting that fermentation can undercut fossil-fuel-based manufacturing on cost as the technology matures.
Synthetic biology companies have engineered microorganisms capable of producing, through fermentation, a growing range of chemicals and materials that have traditionally been derived from petroleum, including certain plastics precursors, fragrance compounds, and specialty industrial chemicals, offering a potential lower-carbon manufacturing alternative to conventional petrochemical production.
Early commercial products from this approach have generally targeted higher-value specialty chemicals rather than bulk commodity materials, since the economics of fermentation-based production currently favor products where quality and sustainability credentials command a price premium over the cheapest possible per-unit cost.
Scaling to bulk commodity chemicals remains the harder problem
Producing bulk commodity chemicals at the scale and cost of conventional petrochemical manufacturing remains a considerably harder engineering and economic challenge, since fermentation processes generally need substantial further optimization in yield and production speed to compete on pure cost with decades-optimized petrochemical infrastructure.
“We can already beat petroleum on cost for specialty chemicals where sustainability commands a premium. Bulk commodities are a much longer road.”
With investment in the sector continuing to grow and several companies reporting steady yield improvements, industry observers generally expect fermentation-based manufacturing to keep expanding into higher-value specialty markets first, with genuine competition for bulk commodity chemicals remaining a longer-term goal rather than a near-term reality.